121 related articles for article (PubMed ID: 9305866)
1. Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin 1.
Francisco JA; Gawlak SL; Siegall CB
J Biol Chem; 1997 Sep; 272(39):24165-9. PubMed ID: 9305866
[TBL] [Abstract][Full Text] [Related]
2. Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture.
Francisco JA; Gawlak SL; Miller M; Bathe J; Russell D; Chace D; Mixan B; Zhao L; Fell HP; Siegall CB
Bioconjug Chem; 1997; 8(5):708-13. PubMed ID: 9327135
[TBL] [Abstract][Full Text] [Related]
3. Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen.
Francisco JA; Gilliland LK; Stebbins MR; Norris NA; Ledbetter JA; Siegall CB
Cancer Res; 1995 Jul; 55(14):3099-104. PubMed ID: 7541711
[TBL] [Abstract][Full Text] [Related]
4. Single-chain immunotoxins targeted to CD40 for the treatment of human B-lineage hematologic malignancies.
Francisco JA; Siegall CB
Leuk Lymphoma; 1998 Jul; 30(3-4):237-45. PubMed ID: 9713956
[TBL] [Abstract][Full Text] [Related]
5. Identification of a specific tyrosine residue in Bryodin 1 distinct from the active site but required for full catalytic and cytotoxic activity.
Fryxell DK; Gawlak SL; Dodge RW; Siegall CB
Protein Sci; 1998 Feb; 7(2):318-24. PubMed ID: 9521107
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates.
Siegall CB; Gawlak SL; Chace D; Wolff EA; Mixan B; Marquardt H
Bioconjug Chem; 1994; 5(5):423-9. PubMed ID: 7849072
[TBL] [Abstract][Full Text] [Related]
7. Cytokine activation sensitizes human monocytic and endothelial cells to the cytotoxic effects of an anti-CD40 immunotoxin.
Francisco JA; Kiener PA; Moran-Davis P; Ledbetter JA; Siegall CB
J Immunol; 1996 Aug; 157(4):1652-8. PubMed ID: 8759752
[TBL] [Abstract][Full Text] [Related]
8. In vivo efficacy and toxicity of a single-chain immunotoxin targeted to CD40.
Francisco JA; Schreiber GJ; Comereski CR; Mezza LE; Warner GL; Davidson TJ; Ledbetter JA; Siegall CB
Blood; 1997 Jun; 89(12):4493-500. PubMed ID: 9192773
[TBL] [Abstract][Full Text] [Related]
9. Agonistic activity of a CD40-specific single-chain Fv constructed from the variable regions of mAb G28-5.
Ledbetter JA; Francisco JA; Siegall CB; Gilliland LK; Hollenbaugh D; Aruffo A; Siadak AW; Mischel-Petty N; Grosmaire LS; Gordon ML; Brown TJ; Moran-Davis P; Mittler RS; Kiener PA; Nadler SG
Crit Rev Immunol; 1997; 17(5-6):427-35. PubMed ID: 9419430
[TBL] [Abstract][Full Text] [Related]
10. Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica.
Gawlak SL; Neubauer M; Klei HE; Chang CY; Einspahr HM; Siegall CB
Biochemistry; 1997 Mar; 36(11):3095-103. PubMed ID: 9115985
[TBL] [Abstract][Full Text] [Related]
11. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.
Rosenblum MG; Cheung LH; Liu Y; Marks JW
Cancer Res; 2003 Jul; 63(14):3995-4002. PubMed ID: 12873997
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of human CD7-specific single-chain Fv immunotoxins.
Pauza ME; Doumbia SO; Pennell CA
J Immunol; 1997 Apr; 158(7):3259-69. PubMed ID: 9120282
[TBL] [Abstract][Full Text] [Related]
13. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
[TBL] [Abstract][Full Text] [Related]
14. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.
Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE
Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330
[TBL] [Abstract][Full Text] [Related]
15. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
16. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
[TBL] [Abstract][Full Text] [Related]
17. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells.
Friedman PN; McAndrew SJ; Gawlak SL; Chace D; Trail PA; Brown JP; Siegall CB
Cancer Res; 1993 Jan; 53(2):334-9. PubMed ID: 8417827
[TBL] [Abstract][Full Text] [Related]
18. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
Bolognesi A; Tazzari PL; Olivieri F; Polito L; Lemoli R; Terenzi A; Pasqualucci L; Falini B; Stirpe F
Br J Haematol; 1998 Apr; 101(1):179-88. PubMed ID: 9576199
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD30 immunotoxins with native and recombinant dianthin 30.
Bolognesi A; Tazzari PL; Legname G; Olivieri F; Modena D; Conte R; Stirpe F
Cancer Immunol Immunother; 1995 Feb; 40(2):109-14. PubMed ID: 7882380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
